620 Cranbury Road, Suite 106
East Brunswick, NJ 08816
Cellulite Treatment
Clinical Study Results:
Background
and Purpose
Vacuum
massage
devices are currently used to deliver massage
treatments for aesthetic
improvement in the superficial fat layer of the skin. This study of 48
female
subjects was designed to measure and document the effects of vacuum
massage
treatments with the Synergie AMS™ device. The purpose of this
study was not
only to observe whether changes in the appearance of cellulite may be
derived,
but also to measure whether and to what degree areas treatzed
may expect
to
experience a loss in girth as a result of treatments. The study was
also
intended to determine the effect of adding further factors of exercise
and
nutritional supplements to the Synergie AMS™ treatment
regimen.
Method
To
accommodate the
purpose of the study, four different criteria were established and
applied to
four different groups of women. Groups were identified A, B, C, D.
- Group A received AMS
treatments only.
- Group B received AMS
treatments and took
nutritional supplements.
- Group C received AMS
treatments and added an
exercise regimen.
- Group D received AMS
treatments, took
nutritional supplements, and added an exercise regimen.
To
document results,
subjects were measured and photographed at the start of the study, at
the
midway point, and at the end of the study. Each subject was given a
relative cellulite
rating from 1 to 5, with 1 indicating no visible cellulite, and 5
indicating
most severe cellulite. At the end of the study, subjects were asked to
evaluate
whether they had seen a reduction in the appearance of cellulite.
Subjects
A group
of volunteer
female applicants was screened for meeting essential criteria: age (20
to 50 years old),
weight
(up to 40 pounds over ideal weight), contraindications (did
not have any of
the
conditions listed by the manufacturer as contraindicated).
A total
number
of 48 participants was selected from the applicants who met this
criteria.
During the term of the study, participants were prohibited from taking
any
dietary substances for weight loss purposes except the nutritional
supplements
provided to Groups B and D in conjunction with this study. Over the
eight-week
term of the study, 12 participants discontinued their participation due
to
pregnancy, illness, or inability or unwillingness to comply with
criteria:
Thirty-six participants completed the study including 11 from Group A,
8 from
Group B, 7 from Group C, and 10 from Group D.
Apparatus
The
Synergie AMS™
device manufactured by Dynatronics was used to deliver treatments to
the study
participants. The device offers 10 vacuum settings and a countdown
timer. Two treatment
head sizes were used.
Procedure
All
participants in
all four groups received a 30-minute AMS treatment twice a week for
eight
weeks, for a total of 16 treatments. All participants were instructed
not to
change their current eating habits, to drink 6 to 8 (8-ounce) glasses
of water
daily and up to 3 liters of water on the day of their treatments, and
were
prohibited from participating in a weight loss program during the study
or from
taking any weight loss supplements except those provided to their group
(Groups
B and D) as a part of this study. In addition to these instructions,
participants in each group were given specific rules and instructions
for their
respective groups.
- Group A. No additional
instructions or rules
applied to Group A.
- Group B. This group was
required to take
three nutritional supplements three times daily. The supplements, under
the Synergie NSP™ brand name, included Fat Metabolizer,
CarbAid™, and MetaSlim™.
- Group C. This group was
required to add a
moderate aerobic exercise regimen for 30 minutes 3 to 5 times a week.
- Group D. This group was
required to take the
nutritional supplements described for Group B and was required to add
the exercise regimen described for Group C.
Participants
were
provided with a daily log sheet to record their individual performance.
The log
sheet was reviewed by the AMS treatment technician at each treatment
appointment, and the participant's compliance with the program was
logged in
the participant's file.
The AMS
massage
treatments were delivered primarily to the thigh, hip, abdomen, and
buttocks
areas, and to both right and left sides of the body. At the end of the
fourth
week and at the end of the study, each participant was again measured,
and
photographed. At the end of the study, each participant was asked to
state a
subjective opinion as to whether or not she had seen a reduction in the
appearance of cellulite.
Data was
compiled in
a table with separate tabulations for each of the four groups; A, B, C,
and D.
Measurements for inches lost in the waist, hips, and thighs were added
together
for a total of all inches lost for each individual. Inches lost were
averaged
by group.
Results
Of the
36
participants who completed the study, 100% experienced a loss in girth.
Table I
shows the average inches lost by group. Group A lost an average of 3.4
total
inches in the areas measured. Group B lost an average of 4.5 inches,
Group C an
average of 5.4 inches, and Group D an average of 6.1 inches. Of all 36
participants, 91% reported a visible reduction in the appearance of
cellulite:
31 reported a visible reduction in the appearance of cellulite, 3
reported no
visible reduction, and 2 did not report as they did not have visible
cellulite
at the start of the study. Of the 3 who reported no visible reduction,
one was
a participant in Group A, one in Group C, and one in Group D.
Conclusions
The
reduction in the
appearance of cellulite was essentially the same across all four groups
of
participants. Therefore, it is concluded that the AMS treatments
themselves
were the single most important factor resulting in reduction in the
appearance
of cellulite.
Greater loss of inches was seen when factors of exercise and nutritional supplements were added. The greatest inch loss was seen in the group that added both factors of nutritional supplements
- Blog
- |
- Sitemap
- |
- Disclaimer
- |
- Privacy
